Beta Bionics, Inc. (BBNX) Preferred Stock Liabilities (2023 - 2024)

Beta Bionics (BBNX) posted Preferred Stock Liabilities of $321.4 million for Q4 2024, up 22.8% sequentially from $261.7 million in Q3 2024, and up 22.8% YoY from $261.7 million in Q1 2024.

Beta Bionics, Inc. (BBNX) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends

Beta Bionics (BBNX) has 2 years of Preferred Stock Liabilities data on file, last reported at $321.4 million in Q4 2024.

  • Quarterly Preferred Stock Liabilities rose 22.8% year-over-year to $321.4 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $321.4 million (up 22.8% YoY) and the FY2024 annual result came in at $321.4 million, up 22.8% from the prior year.
  • Preferred Stock Liabilities rose to $321.4 million in Q4 2024 per BBNX's latest filing, from $261.7 million in the prior quarter.
  • The five-year high for Preferred Stock Liabilities was $321.4 million in Q4 2024, with the low at $261.7 million in Q4 2023.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2024 321.37 Mn
Sep 30, 2024 261.71 Mn
Jun 30, 2024 261.71 Mn
Mar 31, 2024 261.71 Mn
Dec 31, 2023 261.71 Mn